Scientific Advisory Committee (SAC)

The MGH Scientific Advisory Committee (SAC) meeting is a two-day event that celebrates key accomplishments of MGH investigators and examines strategies for meeting the challenges currently facing the academic biomedical research community at Mass General.
 
This year, MGH is holding their 71st Scientific Advisory Committee (SAC) meeting on April 3 &4, 2019. The theme of SAC this year will be Mass General’s Most Valuable Research Resource: Our Faculty.
 
The event starts off with a Scientific Poster Session that highlights the ongoing research at MGH followed by a Celebration of Science. During this time, we will present awards for the 2019 Martin Prizes for Clinical and Fundamental Research and the 2019 Goodman Fellowship.
 
The second day of the SAC meeting will be dedicated to highlighting challenges facing our research community and identifying solutions to maintain the extraordinary trajectory of science at Mass General. The program provides an engaging and stimulating day of discussions. We greatly appreciate the MGH research community’s participation and are especially grateful for the participation and the leadership of the SAC members (listed below) who make each year’s meeting a productive and successful event.
We hope to see you there!
 

 

2019 SAC Members


David Altshuler, MD, PhD 
Executive Vice President, Global Researh
Chief Scientific Officer
Vertex Pharmaceuticals 

SAC 2019 through SAC 2023 (1st term)

Constance L. Cepko, PhD
Professor, Genetics and Ophthalmology
Investigator, Howard Hughes Medical Institute
Harvard Medical School
SAC 2015 through SAC 2019 (1st term)

Mark C. Fishman, MD
Professor, Stem Cell and Regenerative Biology
Harvard University
Chief, Pathways Clinical Service
Massachusetts General Hospital
SAC 2016 through SAC 2020 (1st term)

Elazer R. Edelman, MD, PhD
Professor, Medical Engineering and Science
Director, Institute for Medical Engineering and Science (IMES)
Massachusetts Institute of Technology
SAC 2019 through SAC 2023 (1st term)

Elaine Fuchs, PhD
Investigator, Howard Hughes Medical Institute
Rebecca C. Lancefield Professor of Mammalian Cell Biology and Development
The Rockefeller University
SAC 2018 through SAC 2022 (1st term)

Richard O. Hynes, PhD
Daniel K. Ludwig Professor for Cancer Research
Investigator, Howard Hughes Medical Institute
Massachusetts Institute of Technology
SAC 2018 through SAC 2022 (2nd term)

Talmadge E. King, Jr., MD
Dean, School of Medicine
Vice Chancellor, Medical Affairs
University of California, San Francisco
SAC 2019 through SAC 2023 (1st term)

Vivian S. Lee, MD, PhD, MBA
President, Health Platforms, Verily Life Sciences
Senior Fellow, Institute for Healthcare Improvement
SAC 2015 through SAC 2019 (1st term)

Douglas A. Melton, PhD
Xander University Professor
Co-Director, Harvard Stem Cell Institute
Investigator, Howard Hughes Medical Institute
Harvard University
SAC 2018 through SAC 2022 (1st term)

Daniel K. Podolsky, MD
President
University of Texas Southwestern Medical Center
SAC 2014 through SAC 2018 (1st term)

Selwyn M. Vickers, MD
Senior Vice President, Medicine
Dean, School of Medicine
University of Alabama at Birmingham
SAC 2019 through SAC 2023 (1st term)

Ex Officio
George Q. Daley, MD, PhD
Dean, Faculty of Medicine
Caroline Shields Walker Professor of Medicine
Investigator, Howard Hughes Medical Institute
Harvard Medical School 
Ex-Officio